Argent Development Group, 809 Arroyo Rd, Los Altos, CA 94024, US

IDEAYA Biosciences, Inc is a clinical-stage precision medicine oncology company headquartered in South San Francisco, California. They are dedicated to the discovery and development of targeted therapeutics for cancer patients using molecular diagnostics. With a focus on synthetic lethality, an emerging class of precision medicine targets, IDEAYA aims to deliver first-in-class and best-in-class therapeutics that have the potential to transform patient outcomes. IDEAYA was founded on the belief that attracting top scientists and focusing on transformative research is key to developing game-changing medicines. Their integrated approach combines biomarker and target discovery with the development of small molecule and protein degrader therapeutics, from early discovery through clinical development. By leveraging the concept of synthetic lethality, IDEAYA seeks to inhibit target proteins in patient populations selected based on genetic alterations, addressing unmet needs in cancer treatment.Generated from the website